Join Dr. Jeffrey Hoch for a talk recognizing some of the academic contributions of the late Professor Bernie O’Brien and how they are still relevant to HTA today.
As part of our commitment to stakeholder engagement, CADTH is inviting patient advocacy groups, clinicians, pharmaceutical manufacturers, associations, and consultants to attend an information and feedback session on the transition of pCODR to CADTH.
The purpose of the sessions will be to:
Provide an update on the work to better align the pC...
February 3, 2015 - February 4, 2015
Hyatt Regency in Vancouver, British Columbia
Hosted by CADTH in partnership with the British Columbia Ministry of Health, the Centre for Clinical Epidemiology and Evaluation, the Ottawa Hospital Research Institute, and the University of Pennsylvania
Fees: Publicly Funded Organizations — $150.00
Join Professor Stegenga for a discussion about how we can address medical intervention harms, which are often underestimated throughout the clinical trial process.
This engaging webinar will kick off a series of cross-Canada events focused on using lab tests appropriately.
With a significant number of medical decisions being influenced by lab test results, governments, health care administrators, and clinical and lab associations are turning their focus to ensuring lab tests are used appropriately. When l...